hackint0sh/temp-data huggingface dataset:
protocolSection identificationModule nctId: NCT06376942, orgStudyIdInfo id: Int/IEC/2024/SPL-5, briefTitle: A RCT to Compare the Effectiveness of Nebulized Anticholinergics for Cough Suppression During Flexible Bronchoscopy, acronym: NAFCOF, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-04-24, primaryCompletionDateStruct date: 2025-04-25, completionDateStruct date: 2025-06-15, studyFirstPostDateStruct date: 2024-04-22, lastUpdatePostDateStruct date: 2024-04-22, sponsorCollaboratorsModule leadSponsor name: Post Graduate Institute of Medical Education and Research, Chandigarh, class: OTHER, descriptionModule briefSummary: No study has examined the role of inhaled glycopyrrolate on mucus secretion. We hypothesize that nebulized glycopyrrolate will improve bronchoscopy procedure by effectively suppressing airway mucus secretion, thereby decreasing cough, and thus improving patient comfort during bronchoscopy. In this study, we aim to compare the efficacy of nebulized glycopyrrolate versus nebulized ipratropium in suppression of cough during flexible bronchoscopy., conditionsModule conditions: Subjects Undergoing Flexible Bronchoscopy, designModule studyType: INTERVENTIONAL, phases: PHASE2, phases: PHASE3, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: PREVENTION, maskingInfo masking: QUADRUPLE, whoMasked: PARTICIPANT, whoMasked: CARE_PROVIDER, whoMasked: INVESTIGATOR, whoMasked: OUTCOMES_ASSESSOR, enrollmentInfo count: 1050, type: ESTIMATED, armsInterventionsModule interventions name: Glycopyrronium, interventions name: Ipratropium, interventions name: Saline, outcomesModule primaryOutcomes measure: Cough count, secondaryOutcomes measure: Operator-estimated airway secretion, secondaryOutcomes measure: Operator-rated secretions on a visual analogue scale (VAS), secondaryOutcomes measure: Operator-rated cough intensity on a visual analogue scale (VAS), secondaryOutcomes measure: Patient-rated comfort on a visual analogue scale (VAS), secondaryOutcomes measure: Adverse reactions, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 85 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Bronchoscopy suite, PGIMER, city: Chandigarh, zip: 160012, country: India, geoPoint lat: 30.73629, lon: 76.7884, hasResults: False
protocolSection identificationModule nctId: NCT06376929, orgStudyIdInfo id: oralcarbohydrateinpediatric, briefTitle: Oral Carbohydrates in Pediatric Surgery and Random Blood Glucose Level, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-05, primaryCompletionDateStruct date: 2024-08, completionDateStruct date: 2024-09, studyFirstPostDateStruct date: 2024-04-22, lastUpdatePostDateStruct date: 2024-04-25, sponsorCollaboratorsModule leadSponsor name: Cairo University, class: OTHER, descriptionModule briefSummary: The correlation between preoperative oral carbohydrate intake and intraoperative random blood sugar and also the effect on postoperative nausea and vomiting., conditionsModule conditions: Postoperative Nausea and Vomiting, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: CROSSOVER, interventionModelDescription: randomized controlled, primaryPurpose: SCREENING, maskingInfo masking: NONE, enrollmentInfo count: 120, type: ESTIMATED, armsInterventionsModule interventions name: oral carbohydrate containing fluid, outcomesModule primaryOutcomes measure: Mean values of Intraoperative random blood sugar in mg/dl, eligibilityModule sex: ALL, minimumAge: 3 Years, maximumAge: 9 Years, stdAges: CHILD, contactsLocationsModule, hasResults: False
protocolSection identificationModule nctId: NCT06376916, orgStudyIdInfo id: IRB00110863, briefTitle: Comparing Magnesium 2g Versus 4g Versus Placebo in the Incidence of Treating AFF RVR, acronym: ATRIUM, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-04, primaryCompletionDateStruct date: 2025-12, completionDateStruct date: 2026-12, studyFirstPostDateStruct date: 2024-04-22, lastUpdatePostDateStruct date: 2024-04-24, sponsorCollaboratorsModule leadSponsor name: Aurora Health Care, class: OTHER, descriptionModule briefSummary: The purpose of this prospective, randomized, double-blinded study is to further evaluate the safety and efficacy of varying doses of intravenous magnesium in the treatment of AFF RVR., conditionsModule conditions: Tachycardia Atrial, conditions: Atrial Fibrillation, conditions: Atrial Flutter With Rapid Ventricular Response, designModule studyType: INTERVENTIONAL, phases: PHASE3, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: DOUBLE, whoMasked: PARTICIPANT, whoMasked: INVESTIGATOR, enrollmentInfo count: 153, type: ESTIMATED, armsInterventionsModule interventions name: Magnesium Sulfate 2 G, interventions name: Magnesium Sulfate 4 G, interventions name: Saline, outcomesModule primaryOutcomes measure: Ventricular rate control, secondaryOutcomes measure: Time to achieve goal HR (heart rate), secondaryOutcomes measure: Rate of conversion, secondaryOutcomes measure: Incidence of hypotension, secondaryOutcomes measure: Change in heart rate, secondaryOutcomes measure: Clinical need for rescue medication administration, secondaryOutcomes measure: Adverse effects, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Advocate Christ Medical Center Emergency Department (ACMC ED), city: Oak Lawn, state: Illinois, zip: 60453, country: United States, contacts name: Marc McDowell, PharmD, role: CONTACT, phone: 708-684-6230, email: marc.mcdowell@aah.org, geoPoint lat: 41.71087, lon: -87.75811, hasResults: False
protocolSection identificationModule nctId: NCT06376903, orgStudyIdInfo id: P.T.REC/012/004860, briefTitle: Effect of Pilates Exercises on Stress Urinary Incontinence in Posmenopausal Women, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-04-20, primaryCompletionDateStruct date: 2024-08-20, completionDateStruct date: 2024-09-20, studyFirstPostDateStruct date: 2024-04-22, lastUpdatePostDateStruct date: 2024-04-22, sponsorCollaboratorsModule leadSponsor name: Cairo University, class: OTHER, descriptionModule briefSummary: • This study will be conducted to determine the effect of pilates exercises on stress urinary incontinence in postmenopausal women, conditionsModule conditions: Urinary Stress Incontinence, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: SINGLE_GROUP, primaryPurpose: TREATMENT, maskingInfo masking: SINGLE, whoMasked: PARTICIPANT, enrollmentInfo count: 60, type: ESTIMATED, armsInterventionsModule interventions name: Pilates exercise - pelvic floor exercise - home advices, outcomesModule primaryOutcomes measure: • Revised urinary incontinence scale, secondaryOutcomes measure: • Quality of Life Questionnaire (QOL) for stress urinary incontinence, eligibilityModule sex: FEMALE, minimumAge: 50 Years, maximumAge: 60 Years, stdAges: ADULT, contactsLocationsModule, hasResults: False
protocolSection identificationModule nctId: NCT06376877, orgStudyIdInfo id: 2024P000900, briefTitle: Connectomic Targeted TMS Target for Refractory Anxiety, acronym: ConTRA, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-08-01, primaryCompletionDateStruct date: 2028-08-01, completionDateStruct date: 2029-02-01, studyFirstPostDateStruct date: 2024-04-19, lastUpdatePostDateStruct date: 2024-04-19, sponsorCollaboratorsModule leadSponsor name: Brigham and Women's Hospital, class: OTHER, descriptionModule briefSummary: We will perform a randomized sham-controlled trial of aiTBS to an anxiosomatic circuit in patients with anxiety-related disorders (i.e., panic disorder, generalized anxiety disorder, social anxiety disorder, obsessive-compulsive disorder, and post-traumatic stress disorder). 80 participants with an anxiety-related disorder (defined below) will receive 50 active or sham TMS treatments over 5 days (following the SAINT protocol, which is FDA-cleared for MDD. The primary outcome will be the BAI, with a modified recall window to reflect the short treatment interval. Participants randomized to sham will be offered an open-label crossover extension., conditionsModule conditions: Anxiety Disorders, conditions: Mental Disorder, conditions: Psychiatric Disorder, designModule studyType: INTERVENTIONAL, phases: PHASE2, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, interventionModelDescription: Nonresponders may have the option for open label active treatment., primaryPurpose: TREATMENT, maskingInfo masking: QUADRUPLE, whoMasked: PARTICIPANT, whoMasked: CARE_PROVIDER, whoMasked: INVESTIGATOR, whoMasked: OUTCOMES_ASSESSOR, enrollmentInfo count: 80, type: ESTIMATED, armsInterventionsModule interventions name: Transcranial magnetic stimulation, interventions name: Sham transcranial magnetic stimulation, outcomesModule primaryOutcomes measure: Beck Anxiety Inventory (BAI), secondaryOutcomes measure: Inventory of Depression and Anxiety Symptoms-II, secondaryOutcomes measure: Hierarchical Taxonomy of Psychopathology (HiTOP)-Self Report, Distress, Fear, and Mania subfactors, secondaryOutcomes measure: State-Trait Anxiety Inventory, secondaryOutcomes measure: Penn State Worry Questionnaire (PSWQ), secondaryOutcomes measure: Mood/Anxiety Symptoms Questionnaire: Anxious Arousal (MASQ:AA), secondaryOutcomes measure: Anxiety Sensitivity Index (ASI), secondaryOutcomes measure: Intolerance of Uncertainty Scale (IUS), secondaryOutcomes measure: Beck Depression Inventory (BDI), secondaryOutcomes measure: TCI-R140 (Temperament and character inventory, revised 140-question format), secondaryOutcomes measure: Emotional Conflict Resolution Task, secondaryOutcomes measure: Laboratory Fear Extinction Paradigm, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 70 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Emma Jones, city: Boston, state: Massachusetts, zip: 02115, country: United States, contacts name: Emma Jones, role: CONTACT, email: bwhtmsanxiety@mgb.org, geoPoint lat: 42.35843, lon: -71.05977, hasResults: False
protocolSection identificationModule nctId: NCT06376864, orgStudyIdInfo id: RC- FNRA-IG /20-21/SOSC/01, briefTitle: Physical Activity Intervention Effects on Executive Function, Physical Activity and Sedentary Behaviour in Children, statusModule overallStatus: ACTIVE_NOT_RECRUITING, startDateStruct date: 2023-01-01, primaryCompletionDateStruct date: 2024-06-30, completionDateStruct date: 2024-07-30, studyFirstPostDateStruct date: 2024-04-19, lastUpdatePostDateStruct date: 2024-04-19, sponsorCollaboratorsModule leadSponsor name: Hong Kong Baptist University, class: OTHER, descriptionModule briefSummary: The current study aims to implement the Activity Breaks intervention and evaluate its effectiveness on outcome measures of executive function (EF), physical activity (PA), and sedentary behaviour (SB) in school children., conditionsModule conditions: Child Behavior, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: PREVENTION, maskingInfo masking: TRIPLE, whoMasked: PARTICIPANT, whoMasked: CARE_PROVIDER, whoMasked: OUTCOMES_ASSESSOR, enrollmentInfo count: 450, type: ACTUAL, armsInterventionsModule interventions name: Activity Breaks, outcomesModule primaryOutcomes measure: Executive function, primaryOutcomes measure: Psychological capacities, primaryOutcomes measure: Working memory, primaryOutcomes measure: Attention, secondaryOutcomes measure: Physical activity (min/week), secondaryOutcomes measure: Sedentary behavior (hour), secondaryOutcomes measure: Body weight (kg), secondaryOutcomes measure: Height (cm), eligibilityModule sex: ALL, minimumAge: 8 Years, maximumAge: 12 Years, stdAges: CHILD, contactsLocationsModule locations facility: Department of Sport, Physical Education, and Health, Hong Kong Bapist University, city: Kowloon Tong, country: Hong Kong, geoPoint lat: 22.33312, lon: 114.17969, hasResults: False
protocolSection identificationModule nctId: NCT06376851, orgStudyIdInfo id: CP-910-001, briefTitle: AI DErived Plaque Quantification: CCTA and AI-QCPA for Determining Effective CAD Management, acronym: DECIDE, statusModule overallStatus: ENROLLING_BY_INVITATION, startDateStruct date: 2024-03-27, primaryCompletionDateStruct date: 2026-03-27, completionDateStruct date: 2030-03-27, studyFirstPostDateStruct date: 2024-04-19, lastUpdatePostDateStruct date: 2024-04-19, sponsorCollaboratorsModule leadSponsor name: HeartFlow, Inc., class: INDUSTRY, descriptionModule briefSummary: The objective of HeartFlow's DECIDE Registry is to collect observational data about the management of patients before and after HeartFlow Artificial Intelligence-Quantitative Coronary Plaque Analysis (AI-QCPA)., conditionsModule conditions: Coronary Artery Disease, designModule studyType: OBSERVATIONAL, designInfo observationalModel: COHORT, timePerspective: CROSS_SECTIONAL, enrollmentInfo count: 10000, type: ESTIMATED, armsInterventionsModule interventions name: AI-enabled quantitative coronary plaque analysis (AI-QCPA), outcomesModule primaryOutcomes measure: Primary Endpoint, secondaryOutcomes measure: Change in LDL levels, secondaryOutcomes measure: Change in HbA1c levels, secondaryOutcomes measure: Changes in Non HDL levels, secondaryOutcomes measure: Changes in HDL levels, secondaryOutcomes measure: Changes in TG levels, secondaryOutcomes measure: Changes in weight, secondaryOutcomes measure: Reclassification rate of medical management (across the groups), secondaryOutcomes measure: Rates of referral to invasive coronary angiography and coronary revascularization (PCI+CABG), secondaryOutcomes measure: Number of CV hospitalizations, otherOutcomes measure: Number of MACE (CV-related death, MI, or CAD hospitalization), otherOutcomes measure: Timing of referral to other provider(s) for management, otherOutcomes measure: Timing of lab orders (Group 1 vs. Group 2), otherOutcomes measure: Change in Lp(a) (Group 2), otherOutcomes measure: Change in Lp(a) (Group 4 compared to Group 1), eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Moses Cone Memorial Hospital, city: Greensboro, state: North Carolina, zip: 27401, country: United States, geoPoint lat: 36.07264, lon: -79.79198, hasResults: False
protocolSection identificationModule nctId: NCT06376838, orgStudyIdInfo id: DLV-001-02, briefTitle: To Prove the Non-inferiority of DLMR01 by Evaluating the Injecting Efficacy and Safety DLMR01 and Control for Patients in Crow's Feet, acronym: dermal filler, statusModule overallStatus: COMPLETED, startDateStruct date: 2020-07-07, primaryCompletionDateStruct date: 2021-10-15, completionDateStruct date: 2023-05-04, studyFirstPostDateStruct date: 2024-04-19, lastUpdatePostDateStruct date: 2024-04-19, sponsorCollaboratorsModule leadSponsor name: DEXLEVO, class: INDUSTRY, descriptionModule briefSummary: This clinical study is a confirmatory clinical study to prove that the test device, DLMR01, is non-inferior to the control device, Rejuran®, in terms of temporary wrinkle improvement effect on crow's feet and safety. After applying DLMR01, a test device, and Rejuran®, a control device, respectively to wrinkles around the eyes, randomization to compare and evaluate the temporary wrinkle improvement effect and safety of the two clinical study medical devices, subject-evaluator blinding, pair matching, It was designed as a comparative clinical study., conditionsModule conditions: Crow's Feet Lines, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: DOUBLE, whoMasked: PARTICIPANT, whoMasked: INVESTIGATOR, enrollmentInfo count: 218, type: ACTUAL, armsInterventionsModule interventions name: DLMR01, interventions name: Rejuran, outcomesModule primaryOutcomes measure: Crow's Feet Grading Scale by independent evaluators after 12 weeks of using, secondaryOutcomes measure: (1) The improvement rate of wrinkles evaluated using the Crow's Feet Grading Scale, secondaryOutcomes measure: (2) The improvement rate of wrinkles assessed using the Crow's Feet Grading Scale by independent evaluators after 2 weeks and 4 weeks of using the medical device both during rest and when smiling was evaluated., eligibilityModule sex: ALL, minimumAge: 19 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Chung-ang University Hospital, city: Seoul, state: Dongjak-gu, zip: 06973, country: Korea, Republic of, geoPoint lat: 37.566, lon: 126.9784, hasResults: False
protocolSection identificationModule nctId: NCT06376825, orgStudyIdInfo id: CSV202401, briefTitle: The Efficacy and Acceptability of an Internet-Based Self-Help Program to Reduce Burnout, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-04-15, primaryCompletionDateStruct date: 2024-06-15, completionDateStruct date: 2024-06-15, studyFirstPostDateStruct date: 2024-04-19, lastUpdatePostDateStruct date: 2024-04-19, sponsorCollaboratorsModule leadSponsor name: Ahmet Nalbant, class: OTHER, descriptionModule briefSummary: The goal of this clinical trial is to determine whether an internet-based self-help program reduces burnout in teachers. The study will also evaluate the program's acceptability which means assessing the extent to which users complete the program and find it useful. The main questions it aims to answer are:* Does the program reduce the level of burnout in teachers?* Does the program contribute to an increased sense of meaning for teachers?* How much of the program do teachers finish?, conditionsModule conditions: Burnout, Professional, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: NA, interventionModel: SINGLE_GROUP, interventionModelDescription: The study will be a concurrent multiple-baseline single-case experimental study with participiants randomized to baseline durations., primaryPurpose: TREATMENT, maskingInfo masking: NONE, maskingDescription: In this study participants will be randomized to different baseline durations and randomization will be done by one of the investigators who are blind to participants assessments., enrollmentInfo count: 25, type: ESTIMATED, armsInterventionsModule interventions name: MyLife: An internet-based self-help program to reduce burnout, outcomesModule primaryOutcomes measure: Burnout Assessment Tool, primaryOutcomes measure: Valued Living Questionnaire, secondaryOutcomes measure: Acceptance and Action Questionnaire-2, secondaryOutcomes measure: System Usability Scale, secondaryOutcomes measure: Attendance rate, otherOutcomes measure: Daily measures, eligibilityModule sex: ALL, minimumAge: 22 Years, maximumAge: 65 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: CanSagligi Foundation Center for Contextual Behavioral Science, status: RECRUITING, city: Istanbul, country: Turkey, contacts name: Eda Aksoy, role: CONTACT, phone: +90(216) 269 66 11, email: eda.aksoy@cansagligivakfi.org, contacts name: Ahmet Nalbant, MD, role: PRINCIPAL_INVESTIGATOR, contacts name: Havvanur Uysal Akdemir, MS, role: SUB_INVESTIGATOR, contacts name: Edanur Gürbüz, BA, role: SUB_INVESTIGATOR, contacts name: Meryem Gökçe Yavuz, BA, role: SUB_INVESTIGATOR, contacts name: Kaasım Fatih Yavuz, MD, role: SUB_INVESTIGATOR, geoPoint lat: 41.01384, lon: 28.94966, hasResults: False
protocolSection identificationModule nctId: NCT06376812, orgStudyIdInfo id: 23-0320, briefTitle: No Time to Pause: Physical Activity to Improve Health of Midlife Hispanic Women, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2026-05, primaryCompletionDateStruct date: 2029-01, completionDateStruct date: 2029-01, studyFirstPostDateStruct date: 2024-04-19, lastUpdatePostDateStruct date: 2024-04-19, sponsorCollaboratorsModule leadSponsor name: The University of Texas Medical Branch, Galveston, class: OTHER, descriptionModule briefSummary: This study will test the effects of a physical activity intervention among midlife Hispanic women., conditionsModule conditions: Elevated Blood Pressure, conditions: Perimenopause, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: NA, interventionModel: SINGLE_GROUP, primaryPurpose: PREVENTION, maskingInfo masking: NONE, enrollmentInfo count: 40, type: ESTIMATED, armsInterventionsModule interventions name: Physical activity intervention, outcomesModule primaryOutcomes measure: Days the activity monitor was worn, secondaryOutcomes measure: Physical activity as measured by minutes of moderate-vigorous intensity physical activity at 6 months, secondaryOutcomes measure: Physical activity as measured by minutes of moderate-vigorous intensity physical activity at 6 months, secondaryOutcomes measure: Physical activity as measured by minutes of moderate intensity physical activity at 6 months, secondaryOutcomes measure: Physical activity as measured by minutes of moderate intensity physical activity at 6 months, secondaryOutcomes measure: Physical activity as measured by minutes of vigorous intensity physical activity at 6 months, secondaryOutcomes measure: Physical activity as measured by minutes of vigorous intensity physical activity at 6 months, secondaryOutcomes measure: Physical activity as measured by minutes of light intensity physical activity at 6 months, secondaryOutcomes measure: Physical activity as measured by minutes of light intensity physical activity at 6 months, secondaryOutcomes measure: Physical activity as measured by minutes of total physical activity at 6 months, secondaryOutcomes measure: Physical activity as measured by minutes of total physical activity at 6 months, secondaryOutcomes measure: Systolic blood pressure, secondaryOutcomes measure: Systolic blood pressure, secondaryOutcomes measure: Diastolic blood pressure, secondaryOutcomes measure: Diastolic blood pressure, otherOutcomes measure: Abdominal circumference, otherOutcomes measure: Abdominal circumference, otherOutcomes measure: Body mass index, otherOutcomes measure: Body mass index, eligibilityModule sex: FEMALE, minimumAge: 45 Years, maximumAge: 50 Years, stdAges: ADULT, contactsLocationsModule, hasResults: False